APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastric Mucosal Protective Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gastric Mucosal Protective Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025193 pages

Choose your research edition.

Industry ResearchGastric Mucosal Protective Drug Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastric Mucosal Protective Drug Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Gastric Mucosal Protective Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastric Mucosal Protective Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastric Mucosal Protective Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Gastric Mucosal Protective Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Gastric Mucosal Protective Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gastric Mucosal Protective Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastric Mucosal Protective Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gastric Mucosal Protective Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gastric Mucosal Protective Drug include Zhejaing Yuanlijian, Eisai Co., Teva, LIVZON, Guangdong Huanan Pharma, Bayer, AbbVie, Viatris and Otsuka Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Gastric Mucosal Protective Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gastric Mucosal Protective Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gastric Mucosal Protective Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gastric Mucosal Protective Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Gastric Mucosal Protective Drug Segment by Company

Zhejaing Yuanlijian

Eisai Co.

Teva

LIVZON

Guangdong Huanan Pharma

Bayer

AbbVie

Viatris

Otsuka Pharmaceutical

Nostrum Pharmaceuticals

Endo International

Astellas Pharma

Amneal Pharmaceuticals

Gastric Mucosal Protective Drug Segment by Type

Rebamipide

Sucralfate

Bismuth Potassium Citrate

Other

Gastric Mucosal Protective Drug Segment by Application

Hospital

Retail Pharmacy

Other

Gastric Mucosal Protective Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastric Mucosal Protective Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastric Mucosal Protective Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastric Mucosal Protective Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gastric Mucosal Protective Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gastric Mucosal Protective Drug industry.

Chapter 3: Detailed analysis of Gastric Mucosal Protective Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastric Mucosal Protective Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gastric Mucosal Protective Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Rebamipide Table 3. Key Players of Sucralfate Table 4. Key Players of Bismuth Potassium Citrate Table 3. Key Players of Other Table 4. Global Gastric Mucosal Protective Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Retail Pharmacy Table 7. Key Players of Other Table 8. Global Gastric Mucosal Protective Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Gastric Mucosal Protective Drug Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Gastric Mucosal Protective Drug Market Share by Region (2021-2026) Table 11. Global Gastric Mucosal Protective Drug Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Gastric Mucosal Protective Drug Market Share by Region (2027-2032) Table 13. Gastric Mucosal Protective Drug Industry Trends Table 14. Gastric Mucosal Protective Drug Industry Drivers Table 15. Gastric Mucosal Protective Drug Industry Opportunities and Challenges Table 16. Gastric Mucosal Protective Drug Industry Restraints Table 17. Global Gastric Mucosal Protective Drug Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Gastric Mucosal Protective Drug Revenue Market Share by Company (2021-2026) Table 19. Global Gastric Mucosal Protective Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Gastric Mucosal Protective Drug Key Company Head Office and Area Served Table 21. Global Gastric Mucosal Protective Drug Company, Product Type & Application Table 22. Global Gastric Mucosal Protective Drug Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Gastric Mucosal Protective Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Gastric Mucosal Protective Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Gastric Mucosal Protective Drug Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Gastric Mucosal Protective Drug Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Gastric Mucosal Protective Drug Revenue Market Share by Type (2021-2026) Table 29. Global Gastric Mucosal Protective Drug Revenue Market Share by Type (2027-2032) Table 30. Global Gastric Mucosal Protective Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Gastric Mucosal Protective Drug Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Gastric Mucosal Protective Drug Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Gastric Mucosal Protective Drug Revenue Market Share by Application (2021-2026) Table 34. Global Gastric Mucosal Protective Drug Revenue Market Share by Application (2027-2032) Table 35. Zhejaing Yuanlijian Company Information Table 36. Zhejaing Yuanlijian Business Overview Table 37. Zhejaing Yuanlijian Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Zhejaing Yuanlijian Gastric Mucosal Protective Drug Product Portfolio Table 39. Zhejaing Yuanlijian Recent Development Table 40. Eisai Co. Company Information Table 41. Eisai Co. Business Overview Table 42. Eisai Co. Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Eisai Co. Gastric Mucosal Protective Drug Product Portfolio Table 44. Eisai Co. Recent Development Table 45. Teva Company Information Table 46. Teva Business Overview Table 47. Teva Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Teva Gastric Mucosal Protective Drug Product Portfolio Table 49. Teva Recent Development Table 50. LIVZON Company Information Table 51. LIVZON Business Overview Table 52. LIVZON Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. LIVZON Gastric Mucosal Protective Drug Product Portfolio Table 54. LIVZON Recent Development Table 55. Guangdong Huanan Pharma Company Information Table 56. Guangdong Huanan Pharma Business Overview Table 57. Guangdong Huanan Pharma Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Guangdong Huanan Pharma Gastric Mucosal Protective Drug Product Portfolio Table 59. Guangdong Huanan Pharma Recent Development Table 60. Bayer Company Information Table 61. Bayer Business Overview Table 62. Bayer Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Bayer Gastric Mucosal Protective Drug Product Portfolio Table 64. Bayer Recent Development Table 65. AbbVie Company Information Table 66. AbbVie Business Overview Table 67. AbbVie Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. AbbVie Gastric Mucosal Protective Drug Product Portfolio Table 69. AbbVie Recent Development Table 70. Viatris Company Information Table 71. Viatris Business Overview Table 72. Viatris Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Viatris Gastric Mucosal Protective Drug Product Portfolio Table 74. Viatris Recent Development Table 75. Otsuka Pharmaceutical Company Information Table 76. Otsuka Pharmaceutical Business Overview Table 77. Otsuka Pharmaceutical Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Otsuka Pharmaceutical Gastric Mucosal Protective Drug Product Portfolio Table 79. Otsuka Pharmaceutical Recent Development Table 80. Nostrum Pharmaceuticals Company Information Table 81. Nostrum Pharmaceuticals Business Overview Table 82. Nostrum Pharmaceuticals Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Nostrum Pharmaceuticals Gastric Mucosal Protective Drug Product Portfolio Table 84. Nostrum Pharmaceuticals Recent Development Table 85. Endo International Company Information Table 86. Endo International Business Overview Table 87. Endo International Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Endo International Gastric Mucosal Protective Drug Product Portfolio Table 89. Endo International Recent Development Table 90. Astellas Pharma Company Information Table 91. Astellas Pharma Business Overview Table 92. Astellas Pharma Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Astellas Pharma Gastric Mucosal Protective Drug Product Portfolio Table 94. Astellas Pharma Recent Development Table 95. Amneal Pharmaceuticals Company Information Table 96. Amneal Pharmaceuticals Business Overview Table 97. Amneal Pharmaceuticals Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Amneal Pharmaceuticals Gastric Mucosal Protective Drug Product Portfolio Table 99. Amneal Pharmaceuticals Recent Development Table 100. North America Gastric Mucosal Protective Drug Market Size by Type (2021-2026) & (US$ Million) Table 101. North America Gastric Mucosal Protective Drug Market Size by Type (2027-2032) & (US$ Million) Table 102. North America Gastric Mucosal Protective Drug Market Size by Application (2021-2026) & (US$ Million) Table 103. North America Gastric Mucosal Protective Drug Market Size by Application (2027-2032) & (US$ Million) Table 104. North America Gastric Mucosal Protective Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Gastric Mucosal Protective Drug Market Size by Country (2021-2026) Table 106. North America Gastric Mucosal Protective Drug Market Size by Country (2027-2032) Table 107. Europe Gastric Mucosal Protective Drug Market Size by Type (2021-2026) & (US$ Million) Table 108. Europe Gastric Mucosal Protective Drug Market Size by Type (2027-2032) & (US$ Million) Table 109. Europe Gastric Mucosal Protective Drug Market Size by Application (2021-2026) & (US$ Million) Table 110. Europe Gastric Mucosal Protective Drug Market Size by Application (2027-2032) & (US$ Million) Table 111. Europe Gastric Mucosal Protective Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Gastric Mucosal Protective Drug Market Size by Country (2021-2026) Table 113. Europe Gastric Mucosal Protective Drug Market Size by Country (2027-2032) Table 114. China Gastric Mucosal Protective Drug Market Size by Type (2021-2026) & (US$ Million) Table 115. China Gastric Mucosal Protective Drug Market Size by Type (2027-2032) & (US$ Million) Table 116. China Gastric Mucosal Protective Drug Market Size by Application (2021-2026) & (US$ Million) Table 117. China Gastric Mucosal Protective Drug Market Size by Application (2027-2032) & (US$ Million) Table 118. Asia Gastric Mucosal Protective Drug Market Size by Type (2021-2026) & (US$ Million) Table 119. Asia Gastric Mucosal Protective Drug Market Size by Type (2027-2032) & (US$ Million) Table 120. Asia Gastric Mucosal Protective Drug Market Size by Application (2021-2026) & (US$ Million) Table 121. Asia Gastric Mucosal Protective Drug Market Size by Application (2027-2032) & (US$ Million) Table 122. Asia Gastric Mucosal Protective Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia Gastric Mucosal Protective Drug Market Size by Country (2021-2026) Table 124. Asia Gastric Mucosal Protective Drug Market Size by Country (2027-2032) Table 125. South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Type (2021-2026) & (US$ Million) Table 126. South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Type (2027-2032) & (US$ Million) Table 127. South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Application (2021-2026) & (US$ Million) Table 128. South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Application (2027-2032) & (US$ Million) Table 129. South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Country (2021-2026) Table 131. South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Country (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Gastric Mucosal Protective Drug Product Image Figure 2. Global Gastric Mucosal Protective Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Gastric Mucosal Protective Drug Market Share by Type: 2025 VS 2032 Figure 4. Rebamipide Image Figure 5. Sucralfate Image Figure 6. Bismuth Potassium Citrate Image Figure 7. Other Image Figure 8. Global Gastric Mucosal Protective Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Gastric Mucosal Protective Drug Market Share by Application: 2025 VS 2032 Figure 10. Hospital Image Figure 11. Retail Pharmacy Image Figure 12. Other Image Figure 13. Global Gastric Mucosal Protective Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 15. Global Gastric Mucosal Protective Drug Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Gastric Mucosal Protective Drug Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Gastric Mucosal Protective Drug Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Gastric Mucosal Protective Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Gastric Mucosal Protective Drug Revenue Market Share by Type (2021-2032) Figure 22. Global Gastric Mucosal Protective Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Gastric Mucosal Protective Drug Revenue Market Share by Application (2021-2032) Figure 24. North America Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 25. North America Gastric Mucosal Protective Drug Market Share by Type (2021-2032) Figure 26. North America Gastric Mucosal Protective Drug Market Share by Application (2021-2032) Figure 27. North America Gastric Mucosal Protective Drug Market Share by Country (2021-2032) Figure 28. United States Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 29. Canada Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 31. Europe Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 32. Europe Gastric Mucosal Protective Drug Market Share by Type (2021-2032) Figure 33. Europe Gastric Mucosal Protective Drug Market Share by Application (2021-2032) Figure 34. Europe Gastric Mucosal Protective Drug Market Share by Country (2021-2032) Figure 35. Germany Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 36. France Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 38. Italy Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 39. Russia Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 41. China Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 42. China Gastric Mucosal Protective Drug Market Share by Type (2021-2032) Figure 43. China Gastric Mucosal Protective Drug Market Share by Application (2021-2032) Figure 44. Asia Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 45. Asia Gastric Mucosal Protective Drug Market Share by Type (2021-2032) Figure 46. Asia Gastric Mucosal Protective Drug Market Share by Application (2021-2032) Figure 47. Asia Gastric Mucosal Protective Drug Market Share by Country (2021-2032) Figure 48. Japan Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 52. India Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 53. Australia Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Gastric Mucosal Protective Drug Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Gastric Mucosal Protective Drug Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Gastric Mucosal Protective Drug Market Share by Country (2021-2032) Figure 58. Brazil Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 63. UAE Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 65. Chile Gastric Mucosal Protective Drug Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Rebamipide
  • Sucralfate
  • Bismuth Potassium Citrate
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Zhejaing Yuanlijian
  • Eisai Co.
  • Teva
  • LIVZON
  • Guangdong Huanan Pharma
  • Bayer
  • AbbVie
  • Viatris
  • Otsuka Pharmaceutical
  • Nostrum Pharmaceuticals
  • Endo International
  • Astellas Pharma
  • Amneal Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Gastric Mucosal Protective Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Rebamipide
  5. 1.2.3 Sucralfate
  6. 1.2.4 Bismuth Potassium Citrate
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Gastric Mucosal Protective Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Retail Pharmacy
  12. 1.3.4 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Gastric Mucosal Protective Drug Growth Trends by Region
  15. 1.5.1 Global Gastric Mucosal Protective Drug Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Gastric Mucosal Protective Drug Market Size by Region (2021-2026)
  17. 1.5.3 Gastric Mucosal Protective Drug Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Gastric Mucosal Protective Drug Market Dynamics
  1. 2.1 Gastric Mucosal Protective Drug Industry Trends
  2. 2.2 Gastric Mucosal Protective Drug Industry Drivers
  3. 2.3 Gastric Mucosal Protective Drug Industry Opportunities and Challenges
  4. 2.4 Gastric Mucosal Protective Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Gastric Mucosal Protective Drug Revenue by Company (2021-2026)
  2. 3.2 Global Gastric Mucosal Protective Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Gastric Mucosal Protective Drug Key Company Head office and Area Served
  4. 3.4 Global Gastric Mucosal Protective Drug Company, Product Type & Application
  5. 3.5 Global Gastric Mucosal Protective Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Gastric Mucosal Protective Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Gastric Mucosal Protective Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Gastric Mucosal Protective Drug Tier 1, Tier 2, and Tier 3
4 Gastric Mucosal Protective Drug Market by Type
  1. 4.1 Global Gastric Mucosal Protective Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Gastric Mucosal Protective Drug Market Size by Type (2021-2032)
  3. 4.3 Global Gastric Mucosal Protective Drug Market Size Share by Type (2021-2032)
5 Gastric Mucosal Protective Drug Market by Application
  1. 5.1 Global Gastric Mucosal Protective Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Gastric Mucosal Protective Drug Market Size by Application (2021-2032)
  3. 5.3 Global Gastric Mucosal Protective Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Zhejaing Yuanlijian
  2. 6.1.1 Zhejaing Yuanlijian Company Information
  3. 6.1.2 Zhejaing Yuanlijian Business Overview
  4. 6.1.3 Zhejaing Yuanlijian Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Zhejaing Yuanlijian Gastric Mucosal Protective Drug Product Portfolio
  6. 6.1.5 Zhejaing Yuanlijian Recent Developments
  7. 6.2 Eisai Co.
  8. 6.2.1 Eisai Co. Company Information
  9. 6.2.2 Eisai Co. Business Overview
  10. 6.2.3 Eisai Co. Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Eisai Co. Gastric Mucosal Protective Drug Product Portfolio
  12. 6.2.5 Eisai Co. Recent Developments
  13. 6.3 Teva
  14. 6.3.1 Teva Company Information
  15. 6.3.2 Teva Business Overview
  16. 6.3.3 Teva Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Teva Gastric Mucosal Protective Drug Product Portfolio
  18. 6.3.5 Teva Recent Developments
  19. 6.4 LIVZON
  20. 6.4.1 LIVZON Company Information
  21. 6.4.2 LIVZON Business Overview
  22. 6.4.3 LIVZON Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 LIVZON Gastric Mucosal Protective Drug Product Portfolio
  24. 6.4.5 LIVZON Recent Developments
  25. 6.5 Guangdong Huanan Pharma
  26. 6.5.1 Guangdong Huanan Pharma Company Information
  27. 6.5.2 Guangdong Huanan Pharma Business Overview
  28. 6.5.3 Guangdong Huanan Pharma Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Guangdong Huanan Pharma Gastric Mucosal Protective Drug Product Portfolio
  30. 6.5.5 Guangdong Huanan Pharma Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bayer Gastric Mucosal Protective Drug Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 AbbVie
  38. 6.7.1 AbbVie Company Information
  39. 6.7.2 AbbVie Business Overview
  40. 6.7.3 AbbVie Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 AbbVie Gastric Mucosal Protective Drug Product Portfolio
  42. 6.7.5 AbbVie Recent Developments
  43. 6.8 Viatris
  44. 6.8.1 Viatris Company Information
  45. 6.8.2 Viatris Business Overview
  46. 6.8.3 Viatris Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Viatris Gastric Mucosal Protective Drug Product Portfolio
  48. 6.8.5 Viatris Recent Developments
  49. 6.9 Otsuka Pharmaceutical
  50. 6.9.1 Otsuka Pharmaceutical Company Information
  51. 6.9.2 Otsuka Pharmaceutical Business Overview
  52. 6.9.3 Otsuka Pharmaceutical Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Otsuka Pharmaceutical Gastric Mucosal Protective Drug Product Portfolio
  54. 6.9.5 Otsuka Pharmaceutical Recent Developments
  55. 6.10 Nostrum Pharmaceuticals
  56. 6.10.1 Nostrum Pharmaceuticals Company Information
  57. 6.10.2 Nostrum Pharmaceuticals Business Overview
  58. 6.10.3 Nostrum Pharmaceuticals Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Nostrum Pharmaceuticals Gastric Mucosal Protective Drug Product Portfolio
  60. 6.10.5 Nostrum Pharmaceuticals Recent Developments
  61. 6.11 Endo International
  62. 6.11.1 Endo International Company Information
  63. 6.11.2 Endo International Business Overview
  64. 6.11.3 Endo International Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Endo International Gastric Mucosal Protective Drug Product Portfolio
  66. 6.11.5 Endo International Recent Developments
  67. 6.12 Astellas Pharma
  68. 6.12.1 Astellas Pharma Company Information
  69. 6.12.2 Astellas Pharma Business Overview
  70. 6.12.3 Astellas Pharma Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Astellas Pharma Gastric Mucosal Protective Drug Product Portfolio
  72. 6.12.5 Astellas Pharma Recent Developments
  73. 6.13 Amneal Pharmaceuticals
  74. 6.13.1 Amneal Pharmaceuticals Company Information
  75. 6.13.2 Amneal Pharmaceuticals Business Overview
  76. 6.13.3 Amneal Pharmaceuticals Gastric Mucosal Protective Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Amneal Pharmaceuticals Gastric Mucosal Protective Drug Product Portfolio
  78. 6.13.5 Amneal Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Gastric Mucosal Protective Drug Market Size (2021-2032)
  2. 7.2 North America Gastric Mucosal Protective Drug Market Size by Type
  3. 7.2.1 North America Gastric Mucosal Protective Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Gastric Mucosal Protective Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Gastric Mucosal Protective Drug Market Share by Type (2021-2032)
  6. 7.3 North America Gastric Mucosal Protective Drug Market Size by Application
  7. 7.3.1 North America Gastric Mucosal Protective Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Gastric Mucosal Protective Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Gastric Mucosal Protective Drug Market Share by Application (2021-2032)
  10. 7.4 North America Gastric Mucosal Protective Drug Market Size by Country
  11. 7.4.1 North America Gastric Mucosal Protective Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Gastric Mucosal Protective Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Gastric Mucosal Protective Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Gastric Mucosal Protective Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Gastric Mucosal Protective Drug Market Size (2021-2032)
  2. 8.2 Europe Gastric Mucosal Protective Drug Market Size by Type
  3. 8.2.1 Europe Gastric Mucosal Protective Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Gastric Mucosal Protective Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Gastric Mucosal Protective Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Gastric Mucosal Protective Drug Market Size by Application
  7. 8.3.1 Europe Gastric Mucosal Protective Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Gastric Mucosal Protective Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Gastric Mucosal Protective Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Gastric Mucosal Protective Drug Market Size by Country
  11. 8.4.1 Europe Gastric Mucosal Protective Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Gastric Mucosal Protective Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Gastric Mucosal Protective Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Gastric Mucosal Protective Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Gastric Mucosal Protective Drug Market Size (2021-2032)
  2. 9.2 China Gastric Mucosal Protective Drug Market Size by Type
  3. 9.2.1 China Gastric Mucosal Protective Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Gastric Mucosal Protective Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Gastric Mucosal Protective Drug Market Share by Type (2021-2032)
  6. 9.3 China Gastric Mucosal Protective Drug Market Size by Application
  7. 9.3.1 China Gastric Mucosal Protective Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Gastric Mucosal Protective Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Gastric Mucosal Protective Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Gastric Mucosal Protective Drug Market Size (2021-2032)
  2. 10.2 Asia Gastric Mucosal Protective Drug Market Size by Type
  3. 10.2.1 Asia Gastric Mucosal Protective Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Gastric Mucosal Protective Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Gastric Mucosal Protective Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Gastric Mucosal Protective Drug Market Size by Application
  7. 10.3.1 Asia Gastric Mucosal Protective Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Gastric Mucosal Protective Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Gastric Mucosal Protective Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Gastric Mucosal Protective Drug Market Size by Country
  11. 10.4.1 Asia Gastric Mucosal Protective Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Gastric Mucosal Protective Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Gastric Mucosal Protective Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Gastric Mucosal Protective Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Gastric Mucosal Protective Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Gastric Mucosal Protective Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Gastric Mucosal Protective Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Gastric Mucosal Protective Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst